Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christina Darden"'
Autor:
Christina Darden, Mark Price, David Ray, Grace Goldstein, Diana Goss, Lee Bennett, Diana Garbinsky, Ramya Thota
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-10 (2021)
Abstract Background Long-acting somatostatin analogs (LA SSAs) are approved and recommended for the treatment of patients with advanced neuroendocrine tumors (NETs). Given the long duration of therapy and differences in administration routes, it is i
Externí odkaz:
https://doaj.org/article/7a5bb3f3059146f4bb5221529e84bf10
Autor:
Daneng Li, Christina Darden, Noran Osman, Salma Sayeed, Laurin Jackson, Diana Garbinsky, Aman Chauhan
Publikováno v:
Cancer Management and Research. 14:3009-3020
Daneng Li,1 Christina Darden,2 Noran Osman,3 Salma Sayeed,3 Laurin Jackson,2 Diana Garbinsky,2 Aman Chauhan4 1City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA; 2RTI Health Solutions, Research Triangle Park, NC,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0e899f7e280f34dafbe06af840b632
https://doi.org/10.2147/cmar.s386419
https://doi.org/10.2147/cmar.s386419
Autor:
Christina Darden, Juliet Band, Kimberly Davis, Shrividya Iyer, David J. McSorley, Debanjali Mitra
Publikováno v:
Future oncology (London, England). 15(2)
Aim: To understand treatment satisfaction in patients with advanced or metastatic breast cancer receiving palbociclib plus an aromatase inhibitor or palbociclib plus fulvestrant in a real-world setting. Patients & methods: We performed an observation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18bf36fa62808b15f7b34b5003d130f1
https://pubmed.ncbi.nlm.nih.gov/30207163
https://pubmed.ncbi.nlm.nih.gov/30207163
Autor:
Christina Darden, Kimberly Davis, Shrividya Iyer, Juliet Band, David J. McSorley, Debanjali Mitra
Publikováno v:
The Breast. 41:S27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27de4f19454ed0f3d25457c2bb28a64f
https://doi.org/10.1016/j.breast.2018.08.079
https://doi.org/10.1016/j.breast.2018.08.079
Autor:
Spiros Tzivelekis, Mark Price, Christina Darden, Sarah Marion, Bintu Sherif, David Chandler, James A. Kaye, Jacob Garcia
Publikováno v:
Blood. 126:5585-5585
Introduction: Granulocyte colony-stimulating factors such as pegfilgrastim (Neulasta®) can reduce the incidence of febrile neutropenia, a life-threatening side effect of myelosuppressive chemotherapy. According to current FDA-approved prescribing in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94f9ba377c066578542652f266352ce5
https://doi.org/10.1182/blood.v126.23.5585.5585
https://doi.org/10.1182/blood.v126.23.5585.5585